Mack, M., Janning, M., Loges, S., & Sültmann, H. (2022). The DKTK EXLIQUID consortium - exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients. Journal of laboratory medicine, 46(4), . https://doi.org/10.1515/labmed-2022-0071
Chicago-Zitierstil (17. Ausg.)Mack, Matthias, Melanie Janning, Sonja Loges, und Holger Sültmann. "The DKTK EXLIQUID Consortium - Exploiting Liquid Biopsies to Advance Cancer Precision Medicine for Molecular Tumor Board Patients." Journal of Laboratory Medicine 46, no. 4 (2022). https://doi.org/10.1515/labmed-2022-0071.
MLA-Zitierstil (9. Ausg.)Mack, Matthias, et al. "The DKTK EXLIQUID Consortium - Exploiting Liquid Biopsies to Advance Cancer Precision Medicine for Molecular Tumor Board Patients." Journal of Laboratory Medicine, vol. 46, no. 4, 2022, https://doi.org/10.1515/labmed-2022-0071.